Abstract
Background and ObjectiveDespite the value of spinal cord stimulation (SCS) in treating some patients with focal neuropathic pain, technological advances in stimulator design and treatment protocols have not correlated with significant improvements in clinical outcomes. This may be because incomplete understanding of the mechanisms underlying SCS precludes improvement in clinical efficacy. In this brief review, we (a) review phenomenological effects of SCS, (b) review the literature on proposed spinal sites of action of SCS and (c) propose a novel hypothesis of mechanism of action.ResultsDorsal columns, dorsal roots and dorsal horns have each been proposed as spinal sites of action of SCS. We suggest that evidence in favour of the dorsal columns or dorsal roots as the primary mediators of SCS is weak and propose that the dorsal horn is the crucial site of action. Furthermore, we hypothesize that, based on their location, and neurochemical and morphological properties, dorsal horn islet cells may mediate the effects of SCS.ConclusionsThe precise spinal mechanisms of action of SCS are still unknown. Dorsal horn islet cells have properties that position them to play a key role in analgesic effects of electrical stimulation. Understanding the mechanisms responsible for positive SCS effects are needed for successful translation into clinical dividends.SignificanceWe review possible spinal mechanisms of action of spinal cord stimulation for neuropathic pain, proposing that direct modulation of dorsal horn neurons is crucial. We suggest that mechanistic insights are needed for translation into more favourable clinical outcomes.
Highlights
Spinal cord stimulation (SCS) was first reported as a treatment for pain a half‐century ago (Shealy, Taslitz et al, 1967)
We focus on potential spinal sites of action—that is, what is happening at the site of therapy delivery—recognizing that supraspinal mechanisms contribute to pain reduction (Bantli et al, 1975; Linderoth and Foreman, 1999)
To advance electrical stimulation therapies further, animal models aimed at studying neuronal circuits underlying neuropathic pain and how these circuits are modulated by spinal cord stimulation (SCS) will undoubtedly provide invaluable understanding
Summary
Spinal cord stimulation (SCS) was first reported as a treatment for pain a half‐century ago (Shealy, Taslitz et al, 1967). We propose the dorsal horn as the likely key site of action, and hypothesize that SCS stimulates dorsal horn islet cells to reduce neuropathic pain.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
